Evaluation of diuron (3-[3,4-dichlorophenyl]-1,1-dimethyl urea) in a two-stage mouse skin carcinogenesis assay

Bianca Ferrucio1, Carla Adriene da Silva Franchi, Natália Ferreira Boldrin

  • 1Center for the Evaluation of the Environmental Impact on Human Health (TOXICAM), Department of Pathology, Botucatu Medical School, UNESP - São Paulo State University, Botucatu, São Paulo, Brazil.

Toxicologic Pathology
|June 25, 2010
PubMed

Insights

Diuron, a likely human carcinogen, did not initiate or promote skin cancer in mice during two long-term studies. This suggests diuron

Area of Science:

  • Toxicology and Carcinogenesis
  • Environmental Health
  • Dermatology

Background:

  • Diuron (3-[3,4-dichlorophenyl]-1,1-dimethyl urea) is an herbicide classified as a likely human carcinogen by the U.S. EPA.
  • Previous studies suggested diuron's carcinogenic activity in rodents, but its genotoxic potential and skin carcinogenesis role remain debated.
  • Clarifying diuron's mechanism of action in rodent neoplasia is crucial for assessing human relevance.

Purpose of the Study:

  • To investigate the initiating and promoting potentials of diuron in a mouse skin carcinogenesis model.
  • To evaluate the influence of different solvents (DMSO and acetone) on diuron's potential carcinogenic activity.
  • To assess the relevance of rodent carcinogenicity findings to human health risks.

Main Methods:

  • Two mouse skin carcinogenesis experiments were conducted over 23 and 21 weeks, respectively.
  • Diuron was applied topically using either dimethylsulfoxide (DMSO) or acetone as solvents.
  • The tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) was used, with careful dose and frequency adjustments due to observed skin ulcers.

Main Results:

  • Diuron did not demonstrate any initiating or promoting effect on skin carcinogenesis in mice, irrespective of the solvent used.
  • The study confirmed the need for optimized TPA application protocols in mouse skin models to avoid adverse effects like ulcers.
  • These findings contrast with some previous reports suggesting diuron's carcinogenic activity.

Conclusions:

  • Under the tested conditions, diuron does not appear to initiate or promote skin carcinogenesis in mice.
  • The results question the direct relevance of previously reported rodent skin tumor findings to human exposure scenarios.
  • Further research may be needed to fully elucidate diuron's complex toxicological profile and carcinogenic mechanisms.